Detalles de la búsqueda
1.
Clinical and humoral responses after SARS-CoV-2 breakthrough infections in patients with immunosuppressants.
J Allergy Clin Immunol
; 2024 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38763170
2.
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Allergy
; 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38439527
3.
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
J Autoimmun
; 135: 102984, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621174
4.
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
BMC Infect Dis
; 23(1): 332, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198536
5.
Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce.
J Eur Acad Dermatol Venereol
; 37(1): 123-136, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36018221
6.
Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases.
BMC Med
; 20(1): 100, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35236350
7.
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis
; 81(12): 1757-1766, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357161
8.
Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry.
J Am Acad Dermatol
; 83(5): 1375-1384, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485210
9.
Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): A single-centre, cluster randomized controlled trial.
Contact Dermatitis
; 80(6): 365-373, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30652317
10.
Persistence of seroconversion at 6 months following primary immunisation in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis
; 82(6): 883-885, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36720583
11.
Response to: "Comment on 'Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry'".
J Am Acad Dermatol
; 85(3): e173-e174, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33675862
12.
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study.
J Dermatolog Treat
; 34(1): 2193663, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098906
13.
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.
JAAD Int
; 10: 14-24, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387062
14.
[Abdominal telangiectasias in a newborn]. / Een pasgeborene met vaattekening op de buik.
Ned Tijdschr Geneeskd
; 1662022 10 05.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-36300458
15.
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Lancet Rheumatol
; 4(6): e417-e429, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527808
16.
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Lancet Rheumatol
; 4(5): e338-e350, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317410
17.
Work ability and quality of working life in atopic dermatitis patients treated with dupilumab.
J Dermatol
; 48(9): 1305-1314, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34013539
18.
Learning from disease registries during a pandemic: Moving toward an international federation of patient registries.
Clin Dermatol
; 39(3): 467-478, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518006
19.
The Selection Process for a Web-Based Application to Measure Patient-Reported Outcomes Following the Example of the TREAT NL Registry.
J Invest Dermatol
; 141(6): 1592-1595.e1, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33181143
Resultados
1 -
19
de 19
1
Próxima >
>>